Journal article · 2010 · Open access

Drug Development for Alzheimer's Disease: Recent Progress

Wonjin Ji, Ilho Ha

Experimental Neurobiology, 19(3), 120–131 · Published 31 December 2010 · DOI 10.5607/en.2010.19.3.120

Free PDFView at the publisherCite this paper

In brief

“Drug Development for Alzheimer's Disease: Recent Progress” is a 2010 journal article by Wonjin Ji and Ilho Ha, published in Experimental Neurobiology. OpenAlex counts 7 citations as of 15 November 2026. It is open access: the full text is free to read at Experimental Neurobiology.

Citations
7
Most cited in
2012 (2)
Field-weighted impact
0.33
References
83
Authors
2

Abstract

Alzheimer's disease, the most common cause of dementia, is characterized by two major pathological hallmarks: amyloid plaques and neurofibrillary tangles. Based on these two indicators, an amyloid cascade hypothesis was proposed, and accordingly, most current therapeutic approaches are now focused on the removal of β-amyloid peptides (Aβ from the brain. Additionally, strategies for blocking tau hyperphosphorylation and aggregation have been suggested, including the development of drugs that can block the formation of tangles. However, there are no true disease-modifying drugs in the current market, though many drugs based on theories other than Aβ and tau pathology are under development. The purpose of this review was to provide information on the current development of AD drugs and to discuss the issues related to drug development.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ji, W., & Ha, I. (2010). Drug Development for Alzheimer's Disease: Recent Progress. Experimental Neurobiology, 19(3), 120–131. https://doi.org/10.5607/en.2010.19.3.120

MLA 9

Ji, Wonjin, and Ilho Ha. “Drug Development for Alzheimer's Disease: Recent Progress.” Experimental Neurobiology, vol. 19, no. 3, 2010, pp. 120–131. https://doi.org/10.5607/en.2010.19.3.120.

Chicago

Ji, Wonjin and Ilho Ha. 2010. “Drug Development for Alzheimer's Disease: Recent Progress.” Experimental Neurobiology 19 (3): 120–131. https://doi.org/10.5607/en.2010.19.3.120.

Harvard

Ji, W. and Ha, I. (2010) ‘Drug Development for Alzheimer's Disease: Recent Progress’, Experimental Neurobiology, 19(3), pp. 120–131. doi:10.5607/en.2010.19.3.120.

IEEE

W. Ji and I. Ha, “Drug Development for Alzheimer's Disease: Recent Progress,” Experimental Neurobiology, vol. 19, no. 3, pp. 120–131, 2010, doi: 10.5607/en.2010.19.3.120.

BibTeX

@article{ji2010drug,
  title     = {{Drug Development for Alzheimer's Disease: Recent Progress}},
  author    = {Ji, Wonjin and Ha, Ilho},
  journal   = {Experimental Neurobiology},
  year      = {2010},
  volume    = {19},
  number    = {3},
  pages     = {120--131},
  doi       = {10.5607/en.2010.19.3.120},
  url       = {https://doi.org/10.5607/en.2010.19.3.120}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201222
201311
201411
201511
201611
201711

Its field-weighted citation impact is 0.33: it has been cited 0.33 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • drug development
  • amyloid plaques
  • neurofibrillary tangles
  • amyloid hypothesis
  • amyloid-beta
  • tau hyperphosphorylation
  • tau aggregation

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Ji, W., & Ha, I. (2010). Drug Development for Alzheimer's Disease: Recent Progress. Experimental Neurobiology, 19(3), 120–131. https://doi.org/10.5607/en.2010.19.3.120

How many times has this paper been cited?

7 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Experimental Neurobiology.

Who wrote this paper?

Wonjin Ji, Ilho Ha.

What is the DOI of this paper?

10.5607/en.2010.19.3.120. The permanent link is https://doi.org/10.5607/en.2010.19.3.120.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.